The Preventive Effect of Recombinant Human Growth Factor (rhEGF) on the Recurrence of Radiodermatitis
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-09-16
著者
-
Ryu Seung-hee
Department Of Radiation Oncology University Of Ulsan College Of Medicine Asan Medical Center
-
HONG Joon
Department of Plastic and Reconstructive Surgery, University of Ulsan College of Medicine, Asan Medi
-
LEE Sang-wook
Department of Radiation Oncology, University of Ulsan College of Medicine, Asan Medical Center
-
Lee Sang-wook
Department Of Radiation Oncology University Of Ulsan College Of Medicine Asan Medical Center
-
Lee Sang-wook
Department Of Orthopaedic Surgery School Of Medicine Catholic University Hospital Of Daegu
-
Hong Joon
Department Of Plastic Surgery University Of Ulsan College Of Medicine Asan Medical Center
-
KIM Yeun
Department of Plastic Surgery, University of Ulsan College of Medicine, Asan Medical Center
-
Kim Yeun
Department Of Plastic Surgery University Of Ulsan College Of Medicine Asan Medical Center
-
Kim Yeun
Department Of Physical Therapy Masan University
関連論文
- Therapeutic Effects of Recombinant Human Epidermal Growth Factor (rhEGF) in a Murine Model of Concurrent Chemo-and Radiotherapy-Induced Oral Mucositis
- Recombinant Human Epidermal Growth Factor Accelerates the Proliferation of Irradiated Human Fibroblasts and Keratinocytes in vitro and in vivo
- The Preventive Effect of Recombinant Human Growth Factor (rhEGF) on the Recurrence of Radiodermatitis
- Chemical Bonding at Interfaces between Si (100) and High-K Dielectrics : Competing Effects of i) Process Gas-Substrate and ii) Film Deposition Reactions
- A Predictive Method for Subsequent Avascular Necrosis of the Femoral Head (AVNFH) by Observation of Bleeding From the Cannulated Screw Used for Fixation of Intracapsular Femoral Neck Fractures
- Differences in Plantar Foot Pressure and COP between Flat and Normal Feet During Walking
- Putative progenitor/stem cells isolated from human oral mucosa are resistant to ionizing radiation
- High-dose chemotherapy and autologous stem-cell transplantation in Korean patients with relapsed or refractory Hodgkin lymphoma